Latest News of NKTR
Nektar Therapeutics' (NASDAQ:NKTR) large institutional owners must be happy as stock continues to impress, up 13% over the past week
By Yahoo! Finance |
2 months ago
Institutional ownership of Nektar Therapeutics is over 50%, making stock price sensitive to their trading actions. Notable shareholders include Deep Track Capital, LP and The Vanguard Group, Inc., wit...